Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion type Assertion NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_head.
- NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion description "[Recognized precursor lesions for gastric adenocarcinoma are intestinal metaplasia and spasmolytic polypeptide expressing metaplasia (SPEM), defined here by ectopic CDX2 and TFF2 expression, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_provenance.
- NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion evidence source_evidence_literature NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_provenance.
- NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion SIO_000772 20709804 NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_provenance.
- NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion wasDerivedFrom befree-20140225 NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_provenance.
- NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_assertion wasGeneratedBy ECO_0000203 NP504454.RAr_ZnDAAlRAHyLBENZX7XQbNQGL7Bg5OhbekQLln6sIk130_provenance.